These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 33853472)
1. Anti-carbamylated protein antibodies positivity and disease activity in Hispanic patients with established rheumatoid arthritis: An observational study. Vega-Morales D; Garza-Elizondo MA; Trouw LA; Gonzalez-Torres KI; Torres-Lopez E; Eguia-Bernal M; Loredo-Alanis SA; Gracia-Arechiga TS; Vazquez-Fuentes BR; Castañeda-Martinez DD; Castañeda-Martinez MM; Elizondo-Solis CV; Mendiola-Jimenez A; Salinas-Carmona MC; Herrera-Sandate P; la Garza JAC; Rodriguez-Sanchez GE; Galarza-Delgado DA Mod Rheumatol; 2022 Feb; 32(2):330-337. PubMed ID: 33853472 [TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis-associated antibodies in healthy first-degree relatives of RA patients. Vega-Morales D; Pérez-Barbosa L; Vega-Sevilla LF; Esquivel-Valerio JA; Ramírez-Monterrubio LE; Gonzalez-Torres KI; Leal-Bramasco AS; Elizondo-Solis CV; Mendiola-Jimenez A; Garza-Elizondo MA; Galarza-Delgado DÁ Int J Immunogenet; 2023 Feb; 50(1):19-23. PubMed ID: 36428093 [TBL] [Abstract][Full Text] [Related]
3. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity. Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001 [TBL] [Abstract][Full Text] [Related]
4. In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation. Pertsinidou E; Saevarsdottir S; Manivel VA; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Cornillet M; Serre G; Holmdahl R; Skriner K; Jakobsson PJ; Westerlind H; Askling J; Rönnelid J Ann Rheum Dis; 2024 Feb; 83(3):277-287. PubMed ID: 38049984 [TBL] [Abstract][Full Text] [Related]
5. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients. van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902 [TBL] [Abstract][Full Text] [Related]
6. Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort. Truchetet ME; Dublanc S; Barnetche T; Vittecoq O; Mariette X; Richez C; Blanco P; Mahler M; Contin-Bordes C; Schaeverbeke T; Arthritis Rheumatol; 2017 Dec; 69(12):2292-2302. PubMed ID: 28853240 [TBL] [Abstract][Full Text] [Related]
7. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients. Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800 [TBL] [Abstract][Full Text] [Related]
8. [Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease]. Zhu H; Zhao LJ; Zhou Y; Chen Y Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1003-1007. PubMed ID: 31848494 [TBL] [Abstract][Full Text] [Related]
9. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls. Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484 [TBL] [Abstract][Full Text] [Related]
10. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor. Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699 [TBL] [Abstract][Full Text] [Related]
11. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis. Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911 [TBL] [Abstract][Full Text] [Related]
12. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis. Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028 [TBL] [Abstract][Full Text] [Related]
13. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis. Gan RW; Trouw LA; Shi J; Toes RE; Huizinga TW; Demoruelle MK; Kolfenbach JR; Zerbe GO; Deane KD; Edison JD; Gilliland WR; Norris JM; Holers VM J Rheumatol; 2015 Apr; 42(4):572-9. PubMed ID: 25593232 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients. Elsayed SA; Esmail MA; Ali RM; Mohafez OM Clin Rheumatol; 2019 Oct; 38(10):2683-2689. PubMed ID: 31161487 [TBL] [Abstract][Full Text] [Related]
15. Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing Brevet P; Lattard C; Guillou C; Rottenberg P; Fardellone P; Le-Loët X; Lequerré T; Cosette P; Boyer O; Fréret M; Vittecoq O Front Immunol; 2021; 12():733511. PubMed ID: 34691039 [TBL] [Abstract][Full Text] [Related]
16. Elevated levels of anti-carbamylated protein antibody in patients with rheumatoid arthritis: association with disease activity and bone destruction. Zhang B; Lei Y; Li X; Gao Z; Xia L; Lu J; Shen H J Investig Med; 2020 Aug; 68(6):1186-1192. PubMed ID: 32690598 [TBL] [Abstract][Full Text] [Related]
17. Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis? Ponchel F; van Delft MAM; Xie X; Burska AN; Duquenne L; Trouw LA; Emery P Clin Exp Rheumatol; 2021; 39(1):146-150. PubMed ID: 32662401 [TBL] [Abstract][Full Text] [Related]
18. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976 [TBL] [Abstract][Full Text] [Related]
19. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802 [TBL] [Abstract][Full Text] [Related]
20. Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study. Rasmussen EB; Thiele LS; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hansen AS; Hvid M; Deleuran B; Greisen SR Scand J Rheumatol; 2023 Sep; 52(5):493-497. PubMed ID: 36255383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]